Caffeine-induced inhibition of the activity of glutamate transporter type 3 expressed in Xenopus oocytes

Toxicology Letters

Volumn 217, Issue 2, 2013, Pages 143-148

  Shin, Hyun Jung ^a   Ryu, Jung Hee ^a   Kim, Sang Tae ^b   Zuo, Zhiyi ^c   Do, Sang Hwan ^a  

^a Seoul National University Bundang Hospital   (South Korea)

^b Chungbuk National University Hospital   (South Korea)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Caffeine; Excitatory amino acid transporter type 3; Glutamate transporter; Phosphatidylinositol 3 kinase; Protein kinase C; Xenopus oocyte

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 9 CHLORO 2 (2 FURYL) 5,6 DIHYDRO 5 IMINO 1,2,4 TRIAZOLO[2,3 C]QUINAZOLINE; CAFFEINE; CHELERYTHRINE; MESSENGER RNA; PENTETRAZOLE; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C; STAUROSPORINE; VESICULAR GLUTAMATE TRANSPORTER 3; WORTMANNIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EPILEPTIC DISCHARGE; NONHUMAN; OOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; VOLTAGE CLAMP; XENOPUS;

ANDROSTADIENES; ANIMALS; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; EXCITATORY AMINO ACID TRANSPORTER 3; FEMALE; OOCYTES; PATCH-CLAMP TECHNIQUES; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; RATS; TETRADECANOYLPHORBOL ACETATE; XENOPUS;

RATTUS;

EID: 84872504728     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2012.12.007     Document Type: Article

References (49)

1. Ault B., Olney M.A., Joyner J.L., Boyer C.E., Notrica M.A., Soroko F.E., Wang C.M. Pro-convulsant actions of theophylline and caffeine in the hippocampus: implications for the management of temporal lobe epilepsy. Brain Research 1987, 426(1):93-102.
2. Babu K.M., Zuckerman M.D., Cherkes J.K., Hack J.B. First-onset seizure after use of 5-hour ENERGY. Pediatric Emergency Care 2011, 27(6):539-540.
3. Beart P.M., O'Shea R.D. Transporters for l-glutamate: an update on their molecular pharmacology and pathological involvement. British Journal of Pharmacology 2007, 150(1):5-17.
4. Bolton V.E., Leicht C.H., Scanlon T.S. Postpartum seizure after epidural blood patch and intravenous caffeine sodium benzoate. Anesthesiology 1989, 70(1):146-149.
5. Bonilha L., Li L.M. Heavy coffee drinking and epilepsy. Seizure 2004, 13(4):284-285.
6. Chan S.L., Mayne M., Holden C.P., Geiger J.D., Mattson M.P. Presenilin-1 mutations increase levels of ryanodine receptors and calcium release in PC12 cells and cortical neurons. Journal of Biological Chemistry 2000, 275(24):18195-18200.
7. Chroscinska-Krawczyk M., Jargiello-Baszak M., Walek M., Tylus B., Czuczwar S.J. Caffeine and the anticonvulsant potency of antiepileptic drugs: experimental and clinical data. Pharmacological Reports 2011, 63(1):12-18.
8. Crino P.B., Jin H., Shumate M.D., Robinson M.B., Coulter D.A., Brooks-Kayal A.R. Increased expression of the neuronal glutamate transporter (EAAT3/EAAC1) in hippocampal and neocortical epilepsy. Epilepsia 2002, 43(3):211-218.
9. Cutrufo C., Bortot L., Giachetti A., Manzini S. Differential effects of various xanthines on pentylenetetrazole-induced seizures in rats: an EEG and behavioural study. European Journal of Pharmacology 1992, 222(1):1-6.
10. Czuczwar S.J., Janusz W., Szczepanik B., Kleinrok Z. Influence of CGS 15943 A (a nonxanthine adenosine antagonist) on the protection offered by a variety of antiepileptic drugs against maximal electroshock-induced seizures in mice. Journal of Neural Transmission. General Section 1991, 86(2):127-134.
11. Daly J.W., Butts-Lamb P., Padgett W. Subclasses of adenosine receptors in the central nervous system: interaction with caffeine and related methylxanthines. Cellular and Molecular Neurobiology 1983, 3(1):69-80.
12. Danbolt N.C. Glutamate uptake. Progress in Neurobiology 2001, 65(1):1-105.
13. Danbolt N.C., Chaudhry F.A., Dehnes Y., Lehre K.P., Levy L.M., Ullensvang K., Storm-Mathisen J. Properties and localization of glutamate transporters. Progress in Brain Research 1998, 116:23-43.
14. Davis K.E., Straff D.J., Weinstein E.A., Bannerman P.G., Correale D.M., Rothstein J.D., Robinson M.B. Multiple signaling pathways regulate cell surface expression and activity of the excitatory amino acid carrier 1 subtype of Glu transporter in C6 glioma. Journal of Neuroscience 1998, 18(7):2475-2485.
15. De Sarro A., Grasso S., Zappala M., Nava F., De Sarro G. Convulsant effects of some xanthine derivatives in genetically epilepsy-prone rats. Naunyn-Schmiedebergs Archives of Pharmacology 1997, 356(1):48-55.
16. Do S.H., Fang H.Y., Ham B.M., Zuo Z. The effects of lidocaine on the activity of glutamate transporter EAAT3: the role of protein kinase C and phosphatidylinositol 3-kinase. Anesthesia and Analgesia 2002, 95(5):1263-1268. (Table of contents).
17. Do S.H., Kamatchi G.L., Washington J.M., Zuo Z. Effects of volatile anesthetics on glutamate transporter, excitatory amino acid transporter type 3: the role of protein kinase C. Anesthesiology 2002, 96(6):1492-1497.
18. Dunwiddie T.V., Hoffer B.J., Fredholm B.B. Alkylxanthines elevate hippocampal excitability. Evidence for a role of endogenous adenosine. Naunyn-Schmiedebergs Archives of Pharmacology 1981, 316(4):326-330.
19. Ettinger S.L., Lauener R.W., Duronio V. Protein kinase C delta specifically associates with phosphatidylinositol 3-kinase following cytokine stimulation. Journal of Biological Chemistry 1996, 271(24):14514-14518.
20. Francis A., Fochtmann L. Caffeine augmentation of electroconvulsive seizures. Psychopharmacology 1994, 115(3):320-324.
21. Fredholm B.B. Astra Award Lecture. Adenosine, adenosine receptors and the actions of caffeine. Pharmacology and Toxicology 1995, 76(2):93-101.
22. Gasior M., Borowicz K., Buszewicz G., Kleinrok Z., Czuczwar S.J. Anticonvulsant activity of phenobarbital and valproate against maximal electroshock in mice during chronic treatment with caffeine and caffeine discontinuation. Epilepsia 1996, 37(3):262-268.
23. Gasior M., Borowicz K., Kleinrok Z., Czuczwar S.J. Chronic caffeine and the anticonvulsant potency of antiepileptic drugs against maximal electroshock. Pharmacology, Biochemistry and Behavior 1996, 54(4):639-644.
24. Gonzalez M.I., Robinson M.B. Protein kinase C-dependent remodeling of glutamate transporter function. Molecular Interventions 2004, 4(1):48-58.
25. Harinath S., Sikdar S.K. Inhibition of human TREK-1 channels by caffeine and theophylline. Epilepsy Research 2005, 64(3):127-135.
26. Huang Y., Feng X., Sando J.J., Zuo Z. Critical role of serine 465 in isoflurane-induced increase of cell-surface redistribution and activity of glutamate transporter type 3. Journal of Biological Chemistry 2006, 281(50):38133-38138.
27. Huang Y., Zuo Z. Isoflurane induces a protein kinase C alpha-dependent increase in cell-surface protein level and activity of glutamate transporter type 3. Molecular Pharmacology 2005, 67(5):1522-1533.
28. Iyadurai S.J., Chung S.S. New-onset seizures in adults: possible association with consumption of popular energy drinks. Epilepsy and Behavior 2007, 10(3):504-508.
29. Kang M., Ryu J., Kim J.H., Na H., Zuo Z., Do S.H. Corticosterone decreases the activity of rat glutamate transporter type 3 expressed in Xenopus oocytes. Steroids 2010, 75(13-14):1113-1118.
30. Kaufman K.R., Sachdeo R.C. Caffeinated beverages and decreased seizure control. Seizure 2003, 12(7):519-521.
31. Lachance M.P. The pharmacology and toxicology of caffeine. Journal of Food Safety 1982, 4(2):71-112.
32. Latini R., Bonati M., Castelli D., Garattini S. Dose-dependent kinetics of caffeine in rats. Toxicology Letters 1978, 2(5):267-270.
33. Luszczki J.J., Zuchora M., Sawicka K.M., Kozinska J., Czuczwar S.J. Acute exposure to caffeine decreases the anticonvulsant action of ethosuximide, but not that of clonazepam, phenobarbital and valproate against pentetrazole-induced seizures in mice. Pharmacological Reports 2006, 58(5):652-659.
34. Maragakis N.J., Rothstein J.D. Glutamate transporters in neurologic disease. Archives of Neurology 2001, 58(3):365-370.
35. Mathern G.W., Mendoza D., Lozada A., Pretorius J.K., Dehnes Y., Danbolt N.C., Nelson N., Leite J.P., Chimelli L., Born D.E., Sakamoto A.C., Assirati J.A., Fried I., Peacock W.J., Ojemann G.A., Adelson P.D. Hippocampal GABA and glutamate transporter immunoreactivity in patients with temporal lobe epilepsy. Neurology 1999, 52(3):453-472.
36. Na H.S., Park H.P., Kim C.S., Do S.H., Zuo Z. 17beta-Estradiol attenuates the activity of the glutamate transporter type 3 expressed in Xenopus oocytes. European Journal of Pharmacology 2012, 676(1-3):20-25.
37. Nawrot P., Jordan S., Eastwood J., Rotstein J., Hugenholtz A., Feeley M. Effects of caffeine on human health. Food Additives and Contaminants 2003, 20(1):1-30.
38. Nehlig A., Daval J.L., Debry G. Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Research. Brain Research Reviews 1992, 17(2):139-170.
39. Nieoullon A., Canolle B., Masmejean F., Guillet B., Pisano P., Lortet S. The neuronal excitatory amino acid transporter EAAC1/EAAT3: does it represent a major actor at the brain excitatory synapse?. Journal of Neurochemistry 2006, 98(4):1007-1018.
40. Paech M. Unexpected postpartum seizures associated with post-dural puncture headache treated with caffeine. International Journal of Obstetric Anesthesia 1996, 5(1):43-46.
41. Rothstein J.D., Dykes-Hoberg M., Pardo C.A., Bristol L.A., Jin L., Kuncl R.W., Kanai Y., Hediger M.A., Wang Y., Schielke J.P., Welty D.F. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 1996, 16(3):675-686.
42. Schmidt B., Roberts R.S., Davis P., Doyle L.W., Barrington K.J., Ohlsson A., Solimano A., Tin W. Long-term effects of caffeine therapy for apnea of prematurity. New England Journal of Medicine 2007, 357(19):1893-1902.
43. Simantov R., Crispino M., Hoe W., Broutman G., Tocco G., Rothstein J.D., Baudry M. Changes in expression of neuronal and glial glutamate transporters in rat hippocampus following kainate-induced seizure activity. Brain Research. Molecular Brain Research 1999, 65(1):112-123.
44. Sims K.D., Straff D.J., Robinson M.B. Platelet-derived growth factor rapidly increases activity and cell surface expression of the EAAC1 subtype of glutamate transporter through activation of phosphatidylinositol 3-kinase. Journal of Biological Chemistry 2000, 275(7):5228-5237.
45. Teschemacher H.J., Herz A., Hess R., Novoczek G. Permeation of purine derivatives into the cerebrospinal fluid of dogs. Experientia 1968, 24(1):54-55.
46. Toker A., Cantley L.C. Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature 1997, 387(6634):673-676.
47. Uneyama H., Harata N., Akaike N. Caffeine and related compounds block inhibitory amino acid-gated Cl-currents in freshly dissociated rat hippocampal neurones. British Journal of Pharmacology 1993, 109(2):459-465.
48. Vyleta N.P., Smith S.M. Fast inhibition of glutamate-activated currents by caffeine. PLoS ONE 2008, 3(9):e3155.
49. Wajda I.J., Banay-Schwartz M., Lajtha A. The effect of caffeine on some mouse brain free amino acid levels. Neurochemical Research 1989, 14(4):317-320.